Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Assembly Biosciences (ASMB)

Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Assembly Biosciences TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 USA

www.assemblybio.com Employees: 73 P: 833-509-4583

Sector:

Medical

Description:

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 464,545
Enterprise Value, $K 426,205
Shares Outstanding, K 15,817
Float, K 14,979
% Float 94.70%
Short Interest, K 1,543
Short Float 9.75%
Days to Cover 8.60
Short Volume Ratio 0.52
% of Insider Shareholders 5.30%
% of Institutional Shareholders 19.92%

Financials:

Annual Sales, $ 28,520 K
Annual Net Income, $ -40,180 K
Last Quarter Sales, $ 10,790 K
Last Quarter Net Income, $ -9,200 K
EBIT, $ -43,440 K
EBITDA, $ -46,970 K

Growth:

1-Year Return 84.96%
3-Year Return 64.26%
5-Year Return -58.38%
5-Year Revenue Growth 78.70%
5-Year Earnings Growth 85.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.72 on 11/10/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -4.79
EPS Growth vs. Prev Qtr 45.86%
EPS Growth vs. Prev Year 52.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 02/12/24

ASMB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.01%
Return-on-Assets % -28.61%
Profit Margin % -140.88%
Debt/Equity 0.00
Price/Sales 6.80
Price/Cash Flow N/A
Price/Book 2.54
Book Value/Share 11.55
Interest Coverage -1.21
60-Month Beta 1.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar